125 related articles for article (PubMed ID: 15153603)
1. Redox regulation of the embryonic stem cell transcription factor oct-4 by thioredoxin.
Guo Y; Einhorn L; Kelley M; Hirota K; Yodoi J; Reinbold R; Scholer H; Ramsey H; Hromas R
Stem Cells; 2004; 22(3):259-64. PubMed ID: 15153603
[TBL] [Abstract][Full Text] [Related]
2. Oct-4: gatekeeper in the beginnings of mammalian development.
Pesce M; Schöler HR
Stem Cells; 2001; 19(4):271-8. PubMed ID: 11463946
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of Oct-4 activity by Ewing's sarcoma protein.
Lee J; Rhee BK; Bae GY; Han YM; Kim J
Stem Cells; 2005; 23(6):738-51. PubMed ID: 15917470
[TBL] [Abstract][Full Text] [Related]
4. Identification of DPPA4 and other genes as putative Sox2:Oct-3/4 target genes using a combination of in silico analysis and transcription-based assays.
Chakravarthy H; Boer B; Desler M; Mallanna SK; McKeithan TW; Rizzino A
J Cell Physiol; 2008 Sep; 216(3):651-62. PubMed ID: 18366076
[TBL] [Abstract][Full Text] [Related]
5. Oct-3/4 maintains the proliferative embryonic stem cell state via specific binding to a variant octamer sequence in the regulatory region of the UTF1 locus.
Nishimoto M; Miyagi S; Yamagishi T; Sakaguchi T; Niwa H; Muramatsu M; Okuda A
Mol Cell Biol; 2005 Jun; 25(12):5084-94. PubMed ID: 15923625
[TBL] [Abstract][Full Text] [Related]
6. Identification of Zfp-57 as a downstream molecule of STAT3 and Oct-3/4 in embryonic stem cells.
Akagi T; Usuda M; Matsuda T; Ko MS; Niwa H; Asano M; Koide H; Yokota T
Biochem Biophys Res Commun; 2005 May; 331(1):23-30. PubMed ID: 15845352
[TBL] [Abstract][Full Text] [Related]
7. Engineered zinc finger proteins for controlling stem cell fate.
Bartsevich VV; Miller JC; Case CC; Pabo CO
Stem Cells; 2003; 21(6):632-7. PubMed ID: 14595122
[TBL] [Abstract][Full Text] [Related]
8. Repression of Oct-4 during embryonic cell differentiation correlates with the appearance of TRIF, a transiently induced DNA-binding factor.
Fuhrmann G; Sylvester I; Schöler HR
Cell Mol Biol (Noisy-le-grand); 1999 Jul; 45(5):717-24. PubMed ID: 10512201
[TBL] [Abstract][Full Text] [Related]
9. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues.
Hochedlinger K; Yamada Y; Beard C; Jaenisch R
Cell; 2005 May; 121(3):465-77. PubMed ID: 15882627
[TBL] [Abstract][Full Text] [Related]
10. The embryonic stem cell transcription factors Oct-4 and FoxD3 interact to regulate endodermal-specific promoter expression.
Guo Y; Costa R; Ramsey H; Starnes T; Vance G; Robertson K; Kelley M; Reinbold R; Scholer H; Hromas R
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3663-7. PubMed ID: 11891324
[TBL] [Abstract][Full Text] [Related]
11. Oct-3/4 repression accelerates differentiation of neural progenitor cells in vitro and in vivo.
Okuda T; Tagawa K; Qi ML; Hoshio M; Ueda H; Kawano H; Kanazawa I; Muramatsu M; Okazawa H
Brain Res Mol Brain Res; 2004 Dec; 132(1):18-30. PubMed ID: 15548425
[TBL] [Abstract][Full Text] [Related]
12. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo.
Rosner MH; Vigano MA; Ozato K; Timmons PM; Poirier F; Rigby PW; Staudt LM
Nature; 1990 Jun; 345(6277):686-92. PubMed ID: 1972777
[TBL] [Abstract][Full Text] [Related]
13. High Oct-ane fuel powers the stem cell.
Donovan PJ
Nat Genet; 2001 Nov; 29(3):246-7. PubMed ID: 11687788
[No Abstract] [Full Text] [Related]
14. Oct-4: control of totipotency and germline determination.
Pesce M; Schöler HR
Mol Reprod Dev; 2000 Apr; 55(4):452-7. PubMed ID: 10694754
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation and DNA binding of the octamer binding transcription factor Oct-3.
Rosfjord E; Scholtz B; Lewis R; Rizzino A
Biochem Biophys Res Commun; 1995 Jul; 212(3):847-53. PubMed ID: 7626120
[TBL] [Abstract][Full Text] [Related]
16. Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1.
Zhang J; Tam WL; Tong GQ; Wu Q; Chan HY; Soh BS; Lou Y; Yang J; Ma Y; Chai L; Ng HH; Lufkin T; Robson P; Lim B
Nat Cell Biol; 2006 Oct; 8(10):1114-23. PubMed ID: 16980957
[TBL] [Abstract][Full Text] [Related]
17. Use of altered-specificity binding Oct-4 suggests an absence of pluripotent cell-specific cofactor usage.
Smith AE; Ford KG
Nucleic Acids Res; 2005; 33(18):6011-23. PubMed ID: 16243786
[TBL] [Abstract][Full Text] [Related]
18. Oct-4, scene 1: the drama of mouse development.
Stewart CL
Nat Genet; 2000 Apr; 24(4):328-30. PubMed ID: 10742086
[No Abstract] [Full Text] [Related]
19. Identification of putative downstream genes of Oct-4 by suppression-subtractive hybridization.
Du Z; Cong H; Yao Z
Biochem Biophys Res Commun; 2001 Apr; 282(3):701-6. PubMed ID: 11401518
[TBL] [Abstract][Full Text] [Related]
20. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1.
Hwang CY; Ryu YS; Chung MS; Kim KD; Park SS; Chae SK; Chae HZ; Kwon KS
Oncogene; 2004 Nov; 23(55):8868-75. PubMed ID: 15480426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
